SPGL008
/ 3SBio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2025
A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=96 | Not yet recruiting | Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Monotherapy • New P1 trial • Solid Tumor
1 to 1
Of
1
Go to page
1